Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter]

被引：1

作者：

Phillip, Moshe ^{[1
,2
]}

Achenbach, Peter ^{[3
,4
]}

Addala, Ananta ^{[5
,6
]}

Albanese-O'Neill, Anastasia ^{[7
]}

Battelino, Tadej ^{[8
,9
]}

Bell, Kirstine J. ^{[10
,11
]}

Besser, Rachel E. J. ^{[7
,12
,13
]}

Bonifacio, Ezio ^{[14
,15
,16
]}

Colhoun, Helen M. ^{[17
,18
]}

Couper, Jennifer J. ^{[19
,20
,21
]}

Craig, Maria E. ^{[10
,11
,22
]}

Danne, Thomas

de Beaufort, Carine ^{[23
,24
,25
]}

Dovc, Klemen ^{[8
,9
]}

Dutta, Sanjoy

Ebekozien, Osagie ^{[26
]}

Elding Larsson, Helena ^{[27
,28
]}

Frohnert, Brigitte I. ^{[29
]}

Gallagher, Mary P. ^{[30
]}

Greenbaum, Carla J. ^{[31
,32
]}

Griffin, Kurt J. ^{[33
,34
]}

Hagopian, William ^{[35
]}

Haller, Michael J. ^{[36
,37
]}

Hendriks, Emile ^{[38
,39
]}

Holt, Richard I. G. ^{[40
,41
]}

Ismail, Heba M. ^{[42
]}

Jacobsen, Laura M. ^{[37
]}

Kolb, Leslie E.

Kordonouri, Olga

Lange, Karin ^{[43
]}

Lash, Robert W. ^{[44
]}

Lernmark, Ake ^{[27
]}

Libman, Ingrid ^{[45
]}

Lundgren, Markus ^{[27
,46
]}

Maahs, David M. ^{[5
]}

Marcovecchio, M. Loredana ^{[38
,39
,47
]}

Mathieu, Chantal ^{[48
]}

Oron, Tal ^{[1
,2
]}

Patil, Shivajirao P. ^{[49
]}

Rewers, Marian J. ^{[29
]}

Rich, Stephen S. ^{[50
]}

Schatz, Desmond A. ^{[36
]}

Schulman-Rosenbaum, Rifka ^{[51
]}

Simmons, Kimber M. ^{[29
]}

Sims, Emily K. ^{[42
]}

Skyler, Jay S. ^{[52
]}

Speake, Cate ^{[31
,32
]}

Steck, Andrea K. ^{[29
]}

Tonyushkina, Ksenia N. ^{[53
]}

Veijola, Riitta ^{[54
,55
]}

机构：

[1] Jesse Z & Sara Lea Shafer Inst Endocrinol & Diabet, Natl Ctr Childhood Diabet, Schneider Childrens Med Ctr Israel, Petah Tiqwa, Israel

[2] Tel Aviv Univ, Fac Med & Hlth Sci, Tel Aviv, Israel

[3] German Res Ctr Environm Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany

[4] Tech Univ Munich, Klinikum Rechts Isar, Forschergrp Diabet, Munich, Germany

[5] Stanford Univ, Dept Pediat, Div Pediat Endocrinol, Sch Med, Stanford, CA USA

[6] Stanford Univ, Stanford Diabet Res Ctr, Sch Med, Stanford, CA USA

[7] Breakthrough T1D, Gainesville, FL USA

[8] Univ Ljubljana, Fac Med, Ljubljana, Slovenia

[9] Univ Med Ctr Ljubljana, Ljubljana, Slovenia

[10] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia

[11] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia

[12] Univ Oxford, NIHR Oxford Biomed Res Ctr, JDRF Wellcome Diabet & Inflammat Lab, Wellcome Ctr Human Genet,Nuffield Dept Med, Oxford, England

[13] Univ Oxford, Oxford Childrens Hosp, Oxford, England

[14] Tech Univ Dresden, Fac Med, Ctr Regenerat Therapies Dresden, Dresden, Germany

[15] Univ Clin Carl Gustav Carus TU Dresden, Paul Langerhans Inst Dresden, Fac Med, Helmholtz Ctr Munich, Dresden, Germany

[16] Fac Med, Dresden, Germany

[17] Univ Edinburgh, Inst Genet & Canc, Edinburgh, Scotland

[18] NHS Fife, Dept Publ Hlth, Kirkcaldy, Scotland

[19] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia

[20] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia

[21] Womens & Childrens Hosp, Endocrinol & Diabet Dept, Adelaide, SA, Australia

[22] UNSW Med & Hlth, Sch Clin Med, Discipline Paediat & Child Hlth, Sydney, NSW, Australia

[23] Int Soc Pediat & Adolescent Diabet ISPAD, Berlin, Germany

[24] Ctr Hosp Luxembourg, Pediat Clin, Luxembourg City, Luxembourg

[25] Univ Luxembourg, Fac Sci Technol & Med, Belval Campus, L-4365 Esch Belval, Luxembourg

[26] T1D Exchange, Boston, MA USA

[27] Lund Univ, CRC, Dept Clin Sci Malmo, Malmo, Sweden

[28] Skane Univ Hosp, Dept Pediat, Malmo, Sweden

[29] Univ Colorado Anschutz Med Campus, Barbara Davis Ctr Diabet, Aurora, CO USA

[30] NYU Langone Hlth, NYU Grossman Sch Med, Dept Pediat, Div Pediat Endocrinol,Hassenfeld Childrens Hosp, New York, NY USA

[31] Benaroya Res Inst, Ctr Intervent Immunol, Seattle, WA USA

[32] Benaroya Res Inst, Diabet Program, Seattle, WA USA

[33] Sanford Res, Sioux Falls, SD USA

[34] Univ South Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD USA

[35] Univ Washington, Pacific Northwest Diabet Res Inst, Seattle, WA USA

[36] UNIV FLORIDA, Diabet Inst, Diabet Inst, GAINESVILLE, FL 32611 USA

[37] Univ Florida, COLL MED,DIV ENDOCRINOL, Coll Med, GAINESVILLE, FL USA

[38] Univ Cambridge, Dept Paediat, Cambridge, England

[39] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England

[40] Univ Southampton, Fac Med, Sch Human Dev & Hlth, Southampton, Hampshire, England

[41] Univ Hosp Southampton NHS Fdn Trust, Natl Inst Hlth Res, Southampton, England

[42] Indiana Univ, Sch Med, Indianapolis, IN USA

[43] Hannover Med Sch, Med Psychol, Hannover, Germany

[44] Endocrine Soc, Washington, DC USA

[45] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Div Pediat Endocrinol & Diabet, Pittsburgh, PA USA

[46] Kristianstad Hosp, Dept Radiol, Kristianstad, Sweden

[47] Cambridge Univ Hosp NHS Fdn Trust, Dept Paediat Diabet & Endocrinol, Cambridge, England

[48] Univ Hosp Gasthuisberg, UZ Leuven, Leuven, Belgium

[49] East Carolina Univ, Brody Sch Med, Dept Family Med, Greenville, NC USA

[50] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA

来源：

DIABETOLOGIA | 2025年

关键词：

Autoantibodies; Glucose monitoring; Prevention; Type; 1; diabetes;

D O I：

10.1007/s00125-024-06350-x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：892 / 895

页数：4

共 5 条

[1] Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes
Mallone, Roberto
DIABETOLOGIA, 2024, : 890 - 891
[2] Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes
Phillip, Moshe
Achenbach, Peter
Addala, Ananta
Albanese-O'Neill, Anastasia
Battelino, Tadej
Bell, Kirstine J.
Besser, Rachel E. J.
Bonifacio, Ezio
Colhoun, Helen M.
Couper, Jennifer J.
Craig, Maria E.
Danne, Thomas
de Beaufort, Carine
Dovc, Klemen
Driscoll, Kimberly A.
Dutta, Sanjoy
Ebekozien, Osagie
Larsson, Helena Elding
Feiten, Daniel J.
Frohnert, Brigitte I.
Gabbay, Robert A.
Gallagher, Mary P.
Greenbaum, Carla J.
Griffin, Kurt J.
Hagopian, William
Haller, Michael J.
Hendrieckx, Christel
Hendriks, Emile
Holt, Richard I. G.
Hughes, Lucille
Ismail, Heba M.
Jacobsen, Laura M.
Johnson, Suzanne B.
Kolb, Leslie E.
Kordonouri, Olga
Lange, Karin
Lash, Robert W.
Lernmark, Ake
Libman, Ingrid
Lundgren, Markus
Maahs, David M.
Marcovecchio, M. Loredana
Mathieu, Chantal
Miller, Kellee M.
O'Donnell, Holly K.
Oron, Tal
Patil, Shivajirao P.
Pop-Busui, Rodica
Rewers, Marian J.
Rich, Stephen S.
DIABETES CARE, 2024, 47 (08)
[3] Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes
Phillip, Moshe
Achenbach, Peter
Addala, Ananta
Albanese-O'Neill, Anastasia
Battelino, Tadej
Bell, Kirstine J.
Besser, Rachel E. J.
Bonifacio, Ezio
Colhoun, Helen M.
Couper, Jennifer J.
Craig, Maria E.
Danne, Thomas
de Beaufort, Carine
Dovc, Klemen
Driscoll, Kimberly A.
Dutta, Sanjoy
Ebekozien, Osagie
Larsson, Helena Elding
Feiten, Daniel J.
Frohnert, Brigitte I.
Gabbay, Robert A.
Gallagher, Mary P.
Greenbaum, Carla J.
Griffin, Kurt J.
Hagopian, William
Haller, Michael J.
Hendrieckx, Christel
Hendriks, Emile
Holt, Richard I. G.
Hughes, Lucille
Ismail, Heba M.
Jacobsen, Laura M.
Johnson, Suzanne B.
Kolb, Leslie E.
Kordonouri, Olga
Lange, Karin
Lash, Robert W.
Lernmark, Ake
Libman, Ingrid
Lundgren, Markus
Maahs, David M.
Marcovecchio, M. Loredana
Mathieu, Chantal
Miller, Kellee M.
O'Donnell, Holly K.
Oron, Tal
Patil, Shivajirao P.
Pop-Busui, Rodica
Rewers, Marian J.
Rich, Stephen S.
DIABETOLOGIA, 2024, 67 (09) : 1731 - 1759
[4] Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes ( vol 47, pg 1276, 2024)
Phillip, Moshe
Achenbach, Peter
Addala, Ananta
Albanese-O'Neill, Anastasia
Battelino, Tadej
Bell, Kirstine J.
Besser, Rachel E. J.
Bonifacio, Ezio
Colhoun, Helen M.
Couper, Jennifer J.
Craig, Maria E.
Danne, Thomas
de Beaufort, Carine
Dovc, Klemen
Driscoll, Kimberly A.
Dutta, Sanjoy
Ebekozien, Osagie
Larsson, Helena Elding
Feiten, Daniel J.
Frohnert, Brigitte I.
Gabbay, Robert A.
Gallagher, Mary P.
Greenbaum, Carla J.
Griffin, Kurt J.
Hagopian, William
Haller, Michael J.
Hendrieckx, Christel
Hendriks, Emile
Holt, Richard I. G.
Hughes, Lucille
Ismail, Heba M.
Jacobsen, Laura M.
Johnson, Suzanne B.
Kolb, Leslie E.
Kordonouri, Olga
Lange, Karin
Lash, Robert W.
Lernmark, Ake
Libman, Ingrid
Lundgren, Markus
Maahs, David M.
Marcovecchio, M. Loredana
Mathieu, Chantal
Miller, Kellee M.
O'Donnell, Holly K.
Oron, Tal
Patil, Shivajirao P.
Pop-Busui, Rodica
Rewers, Marian J.
Rich, Stephen S.
DIABETES CARE, 2024, 47 (11) : 2033 - 2033
[5] Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes
Nathan, Brandon M.
Redondo, Maria J.
Ismail, Heba
Jacobsen, Laura
Sims, Emily K.
Palmer, Jerry
Skyler, Jay
Bocchino, Laura
Geyer, Susan
Sosenko, Jay M.
DIABETES CARE, 2022, 45 (02) : 311 - 318

← 1 →